acetaminophen Tablet + acetaminophen Caplet + ibuprofen Liquid-filled capsule + Placebo Tablet + Placebo Caplet + Placebo Liquid-filled capsule

Phase 3Completed
0 views this week 0 watching Active
Interest: 40/100
40
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Post Operative Dental Pain

Conditions

Post Operative Dental Pain

Trial Timeline

Apr 30, 2016 → Oct 5, 2016

About acetaminophen Tablet + acetaminophen Caplet + ibuprofen Liquid-filled capsule + Placebo Tablet + Placebo Caplet + Placebo Liquid-filled capsule

acetaminophen Tablet + acetaminophen Caplet + ibuprofen Liquid-filled capsule + Placebo Tablet + Placebo Caplet + Placebo Liquid-filled capsule is a phase 3 stage product being developed by Johnson & Johnson for Post Operative Dental Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02735122. Target conditions include Post Operative Dental Pain.

What happened to similar drugs?

20 of 20 similar drugs in Post Operative Dental Pain were approved

Approved (20) Terminated (1) Active (0)
raloxifene + PlaceboEli LillyApproved
QUTENZAAstellas PharmaApproved
Teriparatide + Zoledronic AcidEli LillyApproved
teriparatideEli LillyApproved
Teriparatide + RaloxifeneEli LillyApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02735122Phase 3Completed

Competing Products

20 competing products in Post Operative Dental Pain

See all competitors
ProductCompanyStageHype Score
PRF110- oily solution (Ropivacaine)PainReformPhase 2
25
PRF110PainReformPhase 2
21
ENZ215 + ProliaAlkem LaboratoriesPhase 3
40
teriparatide + teriparatide + Placebo + Calcium Supplement + Vitamin D SupplementEli LillyPhase 3
40
raloxifene + PlaceboEli LillyApproved
43
MBX 1416 (INN imapextide)MBX BiosciencesPhase 2
36
MBX 1416 (Part A) + MBX 1416 (Part B) + Placebo + MBX 1416 (Part C)MBX BiosciencesPhase 1
23
teriparatide 20 micrograms/day subcutaneous + calcitonin 100 IU/day subcutaneousEli LillyPhase 3
40
teriparatide 20 micrograms/day subcutaneous + salmon calcitonin 100 IU/day subcutaneousEli LillyPhase 3
40
CT-P41 + US-licensed ProliaCelltrionPhase 3
40
LetrozoleChugai PharmaceuticalPhase 2
35
Eldecalcitol soft capsulesChugai PharmaceuticalPre-clinical
22
LetrozoleChugai PharmaceuticalPhase 2
35
LetrozoleChugai PharmaceuticalPhase 2
35
Placebo + DS-5565Daiichi SankyoPre-clinical
26
YM177 + etodolac + PlaceboAstellas PharmaPhase 3
40
QUTENZAAstellas PharmaApproved
43
QutenzaAstellas PharmaPre-clinical
26
CelecoxibAstellas PharmaPre-clinical
26
ASP8477 + PlaceboAstellas PharmaPhase 2
35